Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

60.25 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 60.25
Bid (Size) 57.79 (1)
Ask (Size) 65.00 (1)
Prev. Close 60.25
Today's Range 60.25 - 60.25
52wk Range 50.20 - 99.32
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Magnificent Stocks You Probably Never Heard Of
You might not have heard of these stocks, but they're worth putting on your radar. 
Via The Motley Fool
Investors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.
Via Chartmill

Performance

YTD
-4.52%
-4.52%
1 Month
+6.60%
+6.60%
3 Month
+8.95%
+8.95%
6 Month
-13.36%
-13.36%
1 Year
-32.42%
-32.42%

More News

Read More
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024
Via InvestorPlace
NASDAQ:LNTH is showing good growth, while it is not too expensive.
Via Chartmill
NASDAQ:LNTH, a strong growth stock, setting up for a breakout.
Via Chartmill
In a market where value is scarce, NASDAQ:LNTH offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
NASDAQ:LNTH—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via Chartmill
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
Via Benzinga
Is NASDAQ:LNTH on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
NASDAQ:LNTH is showing good growth, while it is not too expensive.
Via Chartmill
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
Via Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024
Via InvestorPlace
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Via Chartmill
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
Via Chartmill
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For February 22, 2024
Via Benzinga
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
Via Chartmill
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.